vs
Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and STEM, INC. (STEM). Click either name above to swap in a different company.
MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $47.1M, roughly 1.1× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -71.6%, a 37.7% gap on every dollar of revenue. On growth, MARAVAI LIFESCIENCES HOLDINGS, INC. posted the faster year-over-year revenue change (-11.8% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -11.9%).
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
MRVI vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.9M | $47.1M |
| Net Profit | $-35.7M | $-16.0M |
| Gross Margin | 25.8% | 48.9% |
| Operating Margin | -117.9% | -17.7% |
| Net Margin | -71.6% | -33.9% |
| Revenue YoY | -11.8% | -15.6% |
| Net Profit YoY | -37.7% | 68.8% |
| EPS (diluted) | $-0.24 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.9M | $47.1M | ||
| Q3 25 | $41.6M | $38.2M | ||
| Q2 25 | $47.4M | $38.4M | ||
| Q1 25 | $46.9M | $32.5M | ||
| Q4 24 | $56.6M | $55.8M | ||
| Q3 24 | $69.0M | $29.3M | ||
| Q2 24 | $69.4M | $34.0M | ||
| Q1 24 | $64.2M | $25.5M |
| Q4 25 | $-35.7M | $-16.0M | ||
| Q3 25 | $-25.6M | $-23.8M | ||
| Q2 25 | $-39.6M | $202.5M | ||
| Q1 25 | $-29.9M | $-25.0M | ||
| Q4 24 | $-25.9M | $-51.1M | ||
| Q3 24 | $-97.1M | $-148.3M | ||
| Q2 24 | $-9.8M | $-582.3M | ||
| Q1 24 | $-12.1M | $-72.3M |
| Q4 25 | 25.8% | 48.9% | ||
| Q3 25 | 13.6% | 35.5% | ||
| Q2 25 | 16.4% | 33.4% | ||
| Q1 25 | 16.5% | 32.4% | ||
| Q4 24 | 34.3% | -4.4% | ||
| Q3 24 | 46.7% | 21.2% | ||
| Q2 24 | 44.4% | 27.6% | ||
| Q1 24 | 40.3% | -95.0% |
| Q4 25 | -117.9% | -17.7% | ||
| Q3 25 | -98.6% | -33.6% | ||
| Q2 25 | -139.8% | -34.8% | ||
| Q1 25 | -104.9% | -65.0% | ||
| Q4 24 | -66.7% | -84.4% | ||
| Q3 24 | -239.9% | -493.2% | ||
| Q2 24 | -19.4% | -1705.5% | ||
| Q1 24 | -29.4% | -267.0% |
| Q4 25 | -71.6% | -33.9% | ||
| Q3 25 | -61.4% | -62.2% | ||
| Q2 25 | -83.5% | 527.8% | ||
| Q1 25 | -63.9% | -76.9% | ||
| Q4 24 | -45.8% | -91.6% | ||
| Q3 24 | -140.6% | -506.3% | ||
| Q2 24 | -14.1% | -1712.6% | ||
| Q1 24 | -18.8% | -283.9% |
| Q4 25 | $-0.24 | $-4.40 | ||
| Q3 25 | $-0.18 | $-2.84 | ||
| Q2 25 | $-0.27 | $-1.79 | ||
| Q1 25 | $-0.21 | $-0.15 | ||
| Q4 24 | $-0.21 | $-15.29 | ||
| Q3 24 | $-0.68 | $-18.24 | ||
| Q2 24 | $-0.07 | $-71.81 | ||
| Q1 24 | $-0.09 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.9M | $48.9M |
| Total DebtLower is stronger | $291.8M | — |
| Stockholders' EquityBook value | $212.4M | $-249.4M |
| Total Assets | $770.6M | $308.9M |
| Debt / EquityLower = less leverage | 1.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $216.9M | $48.9M | ||
| Q3 25 | $243.6M | $43.1M | ||
| Q2 25 | $269.9M | $40.8M | ||
| Q1 25 | $285.1M | $58.6M | ||
| Q4 24 | $322.4M | $56.3M | ||
| Q3 24 | $578.2M | $75.4M | ||
| Q2 24 | $573.2M | $89.6M | ||
| Q1 24 | $561.7M | $112.8M |
| Q4 25 | $291.8M | — | ||
| Q3 25 | $292.8M | — | ||
| Q2 25 | $293.9M | — | ||
| Q1 25 | $294.9M | — | ||
| Q4 24 | $295.9M | — | ||
| Q3 24 | $521.7M | — | ||
| Q2 24 | $522.5M | — | ||
| Q1 24 | $523.3M | — |
| Q4 25 | $212.4M | $-249.4M | ||
| Q3 25 | $245.4M | $-235.7M | ||
| Q2 25 | $265.9M | $-214.1M | ||
| Q1 25 | $300.6M | $-417.5M | ||
| Q4 24 | $325.3M | $-398.4M | ||
| Q3 24 | $344.9M | $-344.1M | ||
| Q2 24 | $434.7M | $-203.2M | ||
| Q1 24 | $410.7M | $371.6M |
| Q4 25 | $770.6M | $308.9M | ||
| Q3 25 | $849.2M | $362.6M | ||
| Q2 25 | $897.0M | $379.2M | ||
| Q1 25 | $959.8M | $405.1M | ||
| Q4 24 | $1.0B | $437.4M | ||
| Q3 24 | $1.3B | $537.8M | ||
| Q2 24 | $1.4B | $691.5M | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 0.91× | — | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.8M | $8.2M |
| Free Cash FlowOCF − Capex | $-24.9M | — |
| FCF MarginFCF / Revenue | -49.9% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-70.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.8M | $8.2M | ||
| Q3 25 | $-15.2M | $11.4M | ||
| Q2 25 | $-10.3M | $-21.3M | ||
| Q1 25 | $-9.4M | $8.5M | ||
| Q4 24 | $-14.6M | $-14.7M | ||
| Q3 24 | $13.1M | $-9.4M | ||
| Q2 24 | $17.4M | $-11.9M | ||
| Q1 24 | $-8.5M | $-621.0K |
| Q4 25 | $-24.9M | — | ||
| Q3 25 | $-18.1M | — | ||
| Q2 25 | $-13.1M | — | ||
| Q1 25 | $-14.6M | — | ||
| Q4 24 | $-20.5M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $7.9M | — | ||
| Q1 24 | $-14.1M | — |
| Q4 25 | -49.9% | — | ||
| Q3 25 | -43.4% | — | ||
| Q2 25 | -27.7% | — | ||
| Q1 25 | -31.2% | — | ||
| Q4 24 | -36.2% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | -22.0% | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 8.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
STEM
Segment breakdown not available.
